Gateway 2012: Rommelag - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Rommelag



Your online Gateway to Rommelag in 2012

27905 Meadow Dr., Suite 9
PO Box 2530
Evergreen, CO  80437
303-674-8333
303-670-2666
www.rommelag.com

Don't miss Rommelag at Interphex 2012, May 1–3, Javits Center, New York, N.Y.

About Rommelag

Rommelag custom designs and builds blow/fill/seal machines for advanced aseptic liquid packaging. We serve the pharmaceutical, healthcare, cosmetic and chemical industries. Applications start at 0.1 mL. Packages such as ampoules, vials, bags, bottles, bellows, are all formed, filled, and sealed in one cycle on one machine. This year we are once again a featured company in the Advanced Aseptic Technologies Tour, register at www.interphex.com/Register.

Visit our Booth: # 2617, contact mail@rommelag.com to set an appointment time during the show.

Rommelag® representatives will be at Interphex 2012 to talk with your organization about the advantages of the Blow-Fill-Seal process for all your Advanced Aseptic liquid packaging needs. The Blow-Fill-Seal process is a fully automated Advance Aseptic system for producing Large Volume Parenteral (LVP) and Small Volume Parenteral (SVP) products. Pharmaceutical companies worldwide are switching from glass ampoules and bottles to the durable, lightweight, plastic bottles formed with the Blow–Fill–Seal process. rommelag® has been providing the industry with superior quality machines and support for over 40 years.

 

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here